W.M. Clouston

478 total citations
17 papers, 385 citations indexed

About

W.M. Clouston is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, W.M. Clouston has authored 17 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Genetics and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in W.M. Clouston's work include CRISPR and Genetic Engineering (4 papers), Animal Genetics and Reproduction (4 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers). W.M. Clouston is often cited by papers focused on CRISPR and Genetic Engineering (4 papers), Animal Genetics and Reproduction (4 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers). W.M. Clouston collaborates with scholars based in Australia, United States and South Africa. W.M. Clouston's co-authors include J. F. R. Kerr, Robert I. Richards, Winship Herr, M. Tanaka, Bronwyn A. Evans, R.H. Mortimer, Jim Haralambidis, Ian Lyons, H. M. Lloyd and Ian A. Clark and has published in prestigious journals such as Nucleic Acids Research, The EMBO Journal and Molecular and Cellular Biology.

In The Last Decade

W.M. Clouston

17 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.M. Clouston Australia 11 205 100 70 60 58 17 385
M Hoffman United States 10 300 1.5× 180 1.8× 88 1.3× 132 2.2× 48 0.8× 20 619
Jennifer E. Embury United States 11 275 1.3× 179 1.8× 26 0.4× 43 0.7× 51 0.9× 16 552
Shoshana Israel Israel 12 228 1.1× 137 1.4× 117 1.7× 108 1.8× 17 0.3× 29 488
Keinosuke Fujita Japan 11 146 0.7× 111 1.1× 136 1.9× 24 0.4× 14 0.2× 24 368
Kehui Xiang United States 13 588 2.9× 54 0.5× 80 1.1× 32 0.5× 31 0.5× 21 751
Neekun Sharma United States 12 134 0.7× 87 0.9× 41 0.6× 77 1.3× 69 1.2× 33 369
Helen Kado‐Fong United States 10 139 0.7× 33 0.3× 30 0.4× 75 1.3× 19 0.3× 15 400
R. Miura Japan 11 133 0.6× 44 0.4× 39 0.6× 91 1.5× 20 0.3× 22 350
R. Alper Israel 10 96 0.5× 49 0.5× 32 0.5× 175 2.9× 19 0.3× 15 421
Ines Moretti‐Rojas United States 14 129 0.6× 50 0.5× 106 1.5× 48 0.8× 10 0.2× 25 428

Countries citing papers authored by W.M. Clouston

Since Specialization
Citations

This map shows the geographic impact of W.M. Clouston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.M. Clouston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.M. Clouston more than expected).

Fields of papers citing papers by W.M. Clouston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.M. Clouston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.M. Clouston. The network helps show where W.M. Clouston may publish in the future.

Co-authorship network of co-authors of W.M. Clouston

This figure shows the co-authorship network connecting the top 25 collaborators of W.M. Clouston. A scholar is included among the top collaborators of W.M. Clouston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.M. Clouston. W.M. Clouston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tanaka, Masafumi, W.M. Clouston, & Winship Herr. (1994). The Oct-2 Glutamine-Rich and Proline-Rich Activation Domains Can Synergize with Each Other or Duplicates of Themselves To Activate Transcription. Molecular and Cellular Biology. 14(9). 6046–6055. 22 indexed citations
2.
Tanaka, M., W.M. Clouston, & Winship Herr. (1994). The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription.. Molecular and Cellular Biology. 14(9). 6046–6055. 63 indexed citations
3.
Congiu, M, W.M. Clouston, Ross T. Fernley, & Robert I. Richards. (1992). The function of conserved elements in the promoter of the mouse angiotensinogen gene. Journal of Molecular Endocrinology. 9(1). 19–29. 5 indexed citations
4.
Fowler, Kerry J., W.M. Clouston, R. E. K. Fournier, & Bronwyn A. Evans. (1991). The relaxin gene is located on chromosome 19 in the mouse. FEBS Letters. 292(1-2). 183–186. 10 indexed citations
5.
Yap, Alpha S., et al.. (1990). Acromegaly first diagnosed in pregnancy: The role of bromocriptine therapy. American Journal of Obstetrics and Gynecology. 163(2). 477–478. 22 indexed citations
6.
Clouston, W.M., Chris J. Lloyd, & Robert I. Richards. (1990). Inducible anti-sense RNA for angiotensinogen in stably transformed hepatoma cell lines. Journal of Molecular Endocrinology. 4(2). 107–117. 4 indexed citations
7.
Clouston, W.M.. (1990). The Angiotensinogen Gene of Swiss Mice Is Closely Linked to a Retrovirus-Like Element. DNA and Cell Biology. 9(9). 623–630. 6 indexed citations
8.
Clouston, W.M., et al.. (1989). VIRILIZING ADRENAL ADENOMA IN AN ADULT WITH THE BECKWITH‐WIEDEMANN SYNDROME: PARADOXICAL RESPONSE TO DEXAMETHASONE. Clinical Endocrinology. 31(4). 467–473. 19 indexed citations
9.
Clouston, W.M., R. E. K. Fournier, & Robert I. Richards. (1989). The angiotensinogen gene is located on mouse chromosome 8. FEBS Letters. 255(2). 419–422. 14 indexed citations
10.
Clouston, W.M. & Robert I. Richards. (1989). An allelic polymorphism of the angiotensinogen gene in mice. Nucleic Acids Research. 17(2). 822–822. 6 indexed citations
11.
Clouston, W.M., Ian Lyons, & Robert I. Richards. (1989). Tissue-specific and hormonal regulation of angiotensinogen minigenes in transgenic mice.. The EMBO Journal. 8(11). 3337–3343. 28 indexed citations
12.
Hayward, Nicholas K., Melissa H. Little, R.H. Mortimer, W.M. Clouston, & Peter J. Smith. (1988). Generation of homozygosity at the c-Ha-ras-1 locus on chromosome 11p in an adrenal adenoma from an adult with Wiedemann—Beckwith syndrome. Cancer Genetics and Cytogenetics. 30(1). 127–132. 29 indexed citations
13.
Clouston, W.M., Bronwyn A. Evans, Jim Haralambidis, & Robert I. Richards. (1988). Molecular cloning of the mouse angiotensinogen gene. Genomics. 2(3). 240–248. 47 indexed citations
14.
Clouston, W.M., Bronwyn A. Evans, & Robert I. Richards. (1987). A strategy for assigning end-fragments of genomic DNA cloned into the cosmid vector pJB8. Nucleic Acids Research. 15(23). 10057–10057. 1 indexed citations
15.
Clouston, W.M. & H. M. Lloyd. (1987). Immobilization-induced Hypercalcemia and Regional Osteoporosis. Clinical Orthopaedics and Related Research. 216. 247–252. 15 indexed citations
16.
Clouston, W.M. & J. F. R. Kerr. (1985). Apoptosis, lymphocytotoxicity and the containment of viral infections. Medical Hypotheses. 18(4). 399–404. 79 indexed citations
17.
Clark, Ian A. & W.M. Clouston. (1980). Effects of endotoxin on the histology of intact and athymic mice infected with Plasmodium vinckei petteri. The Journal of Pathology. 131(3). 221–233. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026